M&A Deal Summary |
|
|---|---|
| Date | 2018-09-14 |
| Target | Gemini Bio |
| Sector | Life Science |
| Buyer(s) |
BelHealth Investment Partners
The BroadOak Fund |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2011 |
| PE ASSETS | 500M USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
BelHealth Investment Partners LLC is a private equity firm focused on mid-sized healthcare companies. The Firm looks to invest $20 to $50 million per transaction and specifically targets healthcare services, healthcare products, healthcare distribution, and healthcare IT. BelHealth prefers companies with recurring revenue, high margins, diverse customers, low regulatory oversight, and modest technology risk. Prospective companies are typically profitable with at least $20-$100 million of enterprise value, $10-$100 million of revenue and $2-$10 million of EBITDA. BelHealth was formed in 2011 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 16 |
| Sector (Life Science) | 4 of 4 |
| Type (Buyout (LBO, MBO, MBI)) | 14 of 14 |
| State (California) | 4 of 4 |
| Country (United States) | 16 of 16 |
| Year (2018) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-07-17 |
NavaDerm Partners
New York, New York, United States NavaDerm Partners is an operator of a dermatology platform consists of 19 dermatologists and 2 physician assistants providing comprehensive general dermatology across medical, surgical, and cosmetic procedures. NavaDerm Partners was founded in 2018 and is based in New York City. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-01 |
Care Advantage
Richmond, Virginia, United States Care Advantage is a provider of home healthcare and related services in Virginia. The Company specializes in “one-on-one” quality nursing care in the home for both “unskilled care” and “skilled care” patients. Care Advantage was founded in 1988 and is based in Richmond, Virginia. |
Sell | - |
The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 25 |
| Sector (Life Science) | 4 of 20 |
| Type (Buyout (LBO, MBO, MBI)) | 1 of 1 |
| State (California) | 3 of 9 |
| Country (United States) | 5 of 23 |
| Year (2018) | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-08 |
BioNex Solutions
San Jose, California, United States BioNex Solutions is a privately funded life science company focused on providing customers with advanced technology systems for laboratory automation and liquid handling. BioNex Solutions was founded in 2009 and is based in San Jose, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-12-20 |
Halo Labs
Burlingame, California, United States Halo Labs is revolutionizing biopharmaceutical drug product quality by commercializing low volume, high throughput tools to characterize product stability and safety. From developability assessment through quality control, Halo Labs provides unprecedented insights that reduce development time and improve patient safety. Halo Labs is based in Burlingame, California. |
Buy | - |
